Drug Science partnership to improve patient access to medical cannabis
Posted On March 25, 2020
- Drug Science Medical Cannabis Working Group has formed a partnership with a leading British producer of medical cannabis to help improve patients access to the medicine in the UK.
- The first British producer of cannabis oils and isolates, Avida Global , is to join Drug Science Medical Cannabis Working Group ( MCWG ) to help accelerate access of medical cannabis to patients.
- The MCWG is a consortium of Drug Science experts, industry partners, patient representatives and policy makers that will develop approaches to improving access of medical cannabis in the UK.
- the UK’s groundbreaking Project Twenty21 , Europe’s first and biggest national medical cannabis registry that is exploring the efficacy of medical cannabis for a number of different chronic and untreatable health conditions.
Read full article: healtheuropa.eu